T1	Participants 105 143	chemotherapy for advanced solid tumors
T2	Participants 331 405	227 patients with breast, colorectal, lung and other solid forms of cancer
T3	Participants 518 536	MPA (117 patients)
T4	Participants 540 562	placebo (110 patients)
T5	Participants 1226 1235	MPA group
T6	Participants 1244 1271	the patients given CT alone
